Latest Breaking News On - Verge scientific communications - Page 11 : comparemela.com

Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares

Disc Medicine Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters Option to Purchase Additional Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoNew yorkWedbush pacgrowChristina tartagliaExchange commissionCapital markets corpVerge scientific communicationsMorgan stanleyDisc medicine incSyndicate departmentNicolaus company incorporatedMorgan stanley coProspectus departmentEquity syndicate departmentMedicine announces closing

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

San franciscoUnited statesNew yorkWedbush pacgrowChristina tartagliaCapital markets corpNicolaus company incorporatedSyndicate departmentEquity syndicate departmentMorgan stanleyProspectus departmentMorgan stanley coDisc medicine incVerge scientific communicationsExchange commissionOne montgomery street

Disc Medicine Announces Pricing of Upsized Public Offering

WATERTOWN, Mass., June 13, 2023 (GLOBE NEWSWIRE) Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the.

San franciscoUnited statesNew yorkChristina tartagliaWedbush pacgrowMorgan stanley coVerge scientific communicationsEquity syndicate departmentMorgan stanleyProspectus departmentCapital markets corpExchange commissionDisc medicine incNicolaus company incorporatedSyndicate departmentOne montgomery street

Stock Market | FinancialContent Business Page

United statesNew yorkSan franciscoChristina tartagliaWedbush pacgrowVerge scientific communicationsExchange commissionNicolaus company incorporatedSyndicate departmentMorgan stanleyEquity syndicate departmentMorgan stanley coProspectus departmentCapital markets corpDisc medicine incOne montgomery street

Disc Medicine Opco : Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP) at European Hematology Association (EHA) 2023 Congress - Form 8-K

Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic. | June 9, 2023

Christina tartagliaJohn quiselVerge scientific communicationsExchange commissionEuropean hematology associationDisc medicine incDisc presents positive initial dataErythropoietic protoporphyriaChief executive officerWill savageChief medical officerGlobal impressionX linked protoporphyriaPrivate securities litigation reform actQuarterly reportDisc medicine opco inc stock exchange